“…The requirements for future miniaturized lab-on-a-chip platforms operating at near POC impose the integration of many technical steps typically performed in clinical laboratories, such that a diagnostic result is provided hopefully within 1 hour after sampling [ 45 , 82 , 86 , 87 , 88 , 89 , 90 , 91 , 92 ]. This task will not be trivial, as there are numerous ways to combine microfluidic components and strategies to address the requirements for near POC testing: 1° rapid prototyping and (mass) microfabrication [ 92 , 93 ], 2° microfluidic circuitry, pumping, and valving [ 94 , 95 , 96 , 97 ], 3° sample preparation and cellular lysis schemes leading to extraction, concentration and/or purification of nucleic acids [ 98 , 99 , 100 , 101 , 102 , 103 ], and 4° molecular (isothermal) amplification and/or molecular hybridization [ 104 , 105 , 106 , 107 , 108 , 109 ]. Especially for the management of infectious syndromes at near POC, technology developers must deal with the challenging engineering tasks of (1) handling biochemically complex samples with relatively large volume (1–30 mL), (2) reducing the sample volume by analyte concentration or purification, and (3) integrating mechanical, thermal, and optical detection processes, to ensure an adequate analytical sensitivity, clinical validity, and user-friendliness of the test.…”